Volition enables automated Nu.Q Vet Cancer Test rollout with Fujifilm in Japan

Quick Takeaways:

VolitionRx Limited completed validation of its ChLIA-based Nu.Q Vet Cancer Test with Fujifilm Vet Systems, enabling full lab automation and moving beyond manual plate-based testing.

The automated test, run on the IDS i10 platform, allows higher throughput and faster turnaround, supporting rising demand, already with 1,700+ veterinary hospitals in Japan registered since its 2024 launch.

With ~7M pet dogs in Japan and cancer a leading cause of death, this rollout strengthens access to early cancer screening, while highlighting cross-platform synergy between Volition’s human and veterinary diagnostics portfolio.

Why It Matters?

Automation on the IDS i10 platform lets Volition scale Nu.Q Vet testing volume and speed, making routine cancer screening more practical for large hospital networks.
Deeper integration with Fujifilm Vet Systems in Japan also strengthens Volition’s reference footprint and creates a template for rolling out lab-based Nu.Q assays in other high‑pet‑ownership markets.

Source: PRnewswire

Tanya B

Tanya is a skilled editor at AnimalHealthX, where she plays a key role in shaping high-quality content across animal healthcare. With a keen eye for detail and a strong grasp of industry trends, she ensures every article, interview, and report is accurate, engaging, and impactful. Passionate about storytelling and driven by curiosity, Tanya brings clarity and consistency to complex topics, helping AnimalHealthX deliver trusted insights to its global audience.